Literature DB >> 976322

Effect of neuroleptics and of combinations of d-amphetamine and neuroleptics on 3H-dopamine uptake by homogenates from rat striatum.

J Del Rio, J Madroñal.   

Abstract

Triperidol was found to be a more potent 3H-dopamine uptake inhibitor than chlorpromazine in homogenates from rat striatum. Inhibition kinetics were competitive for triperidol and non-competitive for chlorpromazine. When drugs were given in vivo, d-amphetamine (10 mg/kg) blocked the 3H-dopamine uptake by about 50% whereas the neuroleptics did not modify the process even at highly sedating doses. Combined treatments with d-amphetamine and neuroleptics showed that only triperidol potentiated the blocking effect of d-amphetamine on 3-H-dopamine uptake. However, such a potentiation was not observed when triperidol and d-amphetamine were simultaneously added in vitro. The results tend to suggest that the postulated actions of neuroleptics on presynaptic sites in the striatum may be more important with the butyrophenone, triperidol than with the phenothiazine, chlorpromazine.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 976322     DOI: 10.1016/0014-2999(76)90135-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Effects of captivity on glucose tolerance in dogs.

Authors:  F Lechin; E Coll-Garcia; B van der Dijs; A Bentolila; F Peña; C Rivas
Journal:  Experientia       Date:  1979-07-15

2.  The effects of dopaminergic blocking agents on the glucose tolerance test in 6 humans and 6 dogs.

Authors:  F Lechin; E Coll-García; B van der Dijs; A Bentolila; F Peña; C Rivas
Journal:  Experientia       Date:  1979-07-15

3.  Interaction of CDP-choline with synaptosomal transport of biogenic amines and their precursors in vitro and in vivo in the rat corpus striatum.

Authors:  M Martinet; P Fonlupt; H Pacheco
Journal:  Experientia       Date:  1978-09-15

4.  The uptake and release of [3-H]-2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthlane (ADTN) by striatal nerve terminals.

Authors:  A Davis; P J Roberts; G N Woodruff
Journal:  Br J Pharmacol       Date:  1978-05       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.